Related references
Note: Only part of the references are listed.Placental perfusion: interest and limits
Paul Berveiller et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2017)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Fetal cytomegalovirus infection
Marianne Leruez-Ville et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2017)
Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment
Dirk Kropeit et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study
Marianne Leruez-Ville et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model
Cecile Vinot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Rivaroxaban transfer across the dually perfused isolated human placental cotyledon
Priya Bapat et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
Placental Transfer of Rilpivirine in an Ex Vivo Human Cotyledon Perfusion Model
Laurent Mandelbrot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Placental Transfer of Darunavir in an Ex Vivo Human Cotyledon Perfusion Model
Laurent Mandelbrot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Placental transfer and metabolism: An overview of the experimental models utilizing human placental tissue
Paivi Myllynen et al.
TOXICOLOGY IN VITRO (2013)
Transplacental transfer of oseltamivir and its metabolite using the human perfused placental cotyledon model
Paul Berveiller et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
Peter Lischka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections
L. K. Dropulic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Quality assessment of a placental perfusion protocol
Line Mathiesen et al.
REPRODUCTIVE TOXICOLOGY (2010)
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection
Sheila C. Dollard et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model
Laurent Gavard et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the International Acyclovir Pregnancy Registry, 1984-1999
KM Stone et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2004)
Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects
LH Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action
KK Biron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replication
GW Koszalka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
